{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "text": "The Screened Set includes all participants who signed an informed consent form (ICF).",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "populationDescription": "The Screened Set includes all participants who signed an informed consent form (ICF)."
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "text": "The Enrolled Set includes all participants who were enrolled in the study.",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "populationDescription": "The Enrolled Set includes all participants who were enrolled in the study."
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "text": "The Full Analysis (FA) Set includes all participants who were enrolled in the study and received at least 1 dose of ALXN1840.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "populationDescription": "The Full Analysis (FA) Set includes all participants who were enrolled in the study and received at least 1 dose of ALXN1840."
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "text": "The Per Protocol (PP) Set is a subset of the FA Set who are compliant with the protocol and do not have any major protocol deviations that would impact the interpretability of the primary efficacy endpoint data. The criteria for exclusion from the PP Set will be determined and finalized prior to database lock. The decision to exclude a participant from the PP Set will be made by the Sponsor prior to unblinding of the study data.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "populationDescription": "The Per Protocol (PP) Set is a subset of the FA Set who are compliant with the protocol and do not have any major protocol deviations that would impact the interpretability of the primary efficacy endpoint data. The criteria for exclusion from the PP Set will be determined and finalized prior to database lock. The decision to exclude a participant from the PP Set will be made by the Sponsor prior to unblinding of the study data."
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "text": "The Safety Set includes all participants who received at least 1 dose of ALXN1840. All safety analyses will be performed using the Safety Set.",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "populationDescription": "The Safety Set includes all participants who received at least 1 dose of ALXN1840. All safety analyses will be performed using the Safety Set."
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "text": "The Pharmacokinetic (PK) Analysis Set includes all participants in the Safety Set who have sufficient plasma concentration data to allow for the derivation of at least 1 PK parameter.",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "populationDescription": "The Pharmacokinetic (PK) Analysis Set includes all participants in the Safety Set who have sufficient plasma concentration data to allow for the derivation of at least 1 PK parameter."
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "text": "The Pharmacodynamic (PD) Analysis Set includes all participants in the Safety Set who have sufficient PD data to allow for the derivation of at least 1 PD parameter.",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "populationDescription": "The Pharmacodynamic (PD) Analysis Set includes all participants in the Safety Set who have sufficient PD data to allow for the derivation of at least 1 PD parameter."
      }
    ],
    "characteristics": [],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 0
    }
  }
}